The filing milestone arrives weeks before Sequoia Fund’s approved reorganization is expected to close Oct. 16, with SEQ set to begin NYSE Arca trading Oct. 19.

CoreWeave increased the private offering from $3.0 billion, setting a 2.875% coupon and an initial conversion price of about $97.85 per share.

The all-cash acquisition includes a 40-day go-shop period through October 27 and is expected to close in late 2026 or early 2027, subject to shareholder and regulatory approvals.

Invesco Senior Secured Management, Aventail Capital Group and Brigade Capital Management also joined the preferred investment, whose size and detailed terms were not disclosed.

New Veld will sell its entire 34.39% Alexforbes holding through a company share repurchase and a separate sale to ARC AF Holdings, with closing expected in the first half of 2027.

Cygnus investors backed the scheme with 98.35% of votes cast in favor, while court approval and Kazakhstan consent remain outstanding.

The shares are intended for Magnum’s employee benefit trust, following completion of an earlier 5.4 million-share incentive-related purchase tranche.

SK Capital, Sherfam and Allan Oberman sold 25 million Apotex shares at C$34 each, with all proceeds going to the selling shareholders and none to Apotex.

The German industrial supplier will acquire 9.3 million shares and cancel them after the residual allocation was about 17 times oversubscribed, completing its planned €260 million capital return tied to the Water Management sale.

The proposed notes would finance remaining construction, reimburse prior CleanSpark equity contributions and fund debt-service reserves for the 175 MW Georgia project.